111 Inc (YI)
1.03
+0.02
(+1.98%)
USD |
NASDAQ |
Apr 26, 16:00
1.02
-0.01
(-0.97%)
After-Hours: 20:00
111 Profit Margin (Quarterly): -2.55% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | -2.55% |
| June 30, 2023 | -1.65% |
| March 31, 2023 | -0.86% |
| December 31, 2022 | -2.76% |
| September 30, 2022 | -2.89% |
| June 30, 2022 | -3.14% |
| March 31, 2022 | -3.70% |
| December 31, 2021 | -3.22% |
| September 30, 2021 | -7.56% |
| June 30, 2021 | -5.26% |
| March 31, 2021 | -5.65% |
| December 31, 2020 | -4.94% |
| September 30, 2020 | -4.59% |
| Date | Value |
|---|---|
| June 30, 2020 | -5.72% |
| March 31, 2020 | -7.91% |
| December 31, 2019 | -11.69% |
| September 30, 2019 | -11.10% |
| June 30, 2019 | -11.96% |
| March 31, 2019 | -18.07% |
| December 31, 2018 | -22.59% |
| September 30, 2018 | -25.30% |
| June 30, 2018 | -21.55% |
| March 31, 2018 | -12.71% |
| December 31, 2017 | -23.34% |
| September 30, 2017 | -24.97% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-11.96%
Minimum
Jun 2019
-0.86%
Maximum
Mar 2023
-5.40%
Average
-4.77%
Median
Profit Margin (Quarterly) Benchmarks
| Concord Medical Services Holdings Ltd | -- |
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | -88.09% |
| Zai Lab Ltd | -145.0% |
| ASLAN Pharmaceuticals Ltd | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -9.15% |
| Return on Invested Capital | -34.61% |
| Gross Profit Margin (Quarterly) | 5.20% |
| Operating Margin (Quarterly) | -2.19% |
| Return on Net Operating Assets | -12.96% |